Enhanced humoral and HLA‐A2‐restricted dengue virus‐specific T‐cell responses in humanized BLT NSG mice

Dengue is a mosquito‐borne viral disease of humans, and animal models that recapitulate human immune responses or dengue pathogenesis are needed to understand the pathogenesis of the disease. We recently described an animal model for dengue virus (DENV) infection using humanized NOD‐scid IL2rγnull mice (NSG) engrafted with cord blood haematopoietic stem cells. We sought to further improve this model by co‐transplantation of human fetal thymus and liver tissues into NSG (BLT‐NSG) mice. Enhanced DENV‐specific antibody titres were found in the sera of BLT‐NSG mice compared with human cord blood haematopoietic stem cell‐engrafted NSG mice. Furthermore, B cells generated during the acute phase and in memory from splenocytes of immunized BLT‐NSG mice secreted DENV‐specific IgM antibodies with neutralizing activity. Human T cells in engrafted BLT‐NSG mice secreted interferon‐γ in response to overlapping DENV peptide pools and HLA‐A2 restricted peptides. The BLT‐NSG mice will allow assessment of human immune responses to DENV vaccines and the effects of previous immunity on subsequent DENV infections.

[1]  P. T. N. Sarkis,et al.  Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV‐1 envelope proteins are largely mediated via human CD5+ B cells , 2011, Immunology.

[2]  M. Swanson,et al.  Generation of HIV Latency in Humanized BLT Mice , 2011, Journal of Virology.

[3]  Y. Teo,et al.  Genome-wide association study identifies susceptibility loci for Dengue shock syndrome at MICB and PLCE1 , 2011, Nature Genetics.

[4]  B. Murphy,et al.  Immune response to dengue virus and prospects for a vaccine. , 2011, Annual review of immunology.

[5]  C. Midgley,et al.  An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection , 2010, Journal of Virology.

[6]  M. Ott,et al.  Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated “Human Immune System” Mice , 2010, PloS one.

[7]  G. Screaton,et al.  Immunodominant T-cell responses to dengue virus NS3 are associated with DHF , 2010, Proceedings of the National Academy of Sciences.

[8]  J. Farrar,et al.  Timing of CD8+ T Cell Responses in Relation to Commencement of Capillary Leakage in Children with Dengue , 2010, The Journal of Immunology.

[9]  D. Greiner,et al.  Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. , 2010, Clinical immunology.

[10]  D. Greiner,et al.  Humanized mouse models to study human diseases , 2010, Current opinion in endocrinology, diabetes, and obesity.

[11]  Cameron P Simmons,et al.  Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants. , 2009, The Journal of infectious diseases.

[12]  A. Rothman,et al.  Dengue Virus Infection and Virus-Specific HLA-A2 Restricted Immune Responses in Humanized NOD-scid IL2rγnull Mice , 2009, PloS one.

[13]  R. Jarman,et al.  A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model , 2009, PLoS medicine.

[14]  Mamoru Ito,et al.  The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). , 2009, International immunology.

[15]  R. Rico-Hesse,et al.  Humanized Mice Show Clinical Signs of Dengue Fever according to Infecting Virus Genotype , 2009, Journal of Virology.

[16]  Andrew D. Luster,et al.  Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice , 2009, Journal of Virology.

[17]  J. Garcia,et al.  Functional and phenotypic characterization of the humanized BLT mouse model. , 2008, Current topics in microbiology and immunology.

[18]  A. Rothman,et al.  Understanding the contribution of cellular immunity to dengue disease pathogenesis , 2008, Immunological reviews.

[19]  R. Woodland,et al.  Human BLyS Facilitates Engraftment of Human PBL Derived B Cells in Immunodeficient Mice , 2008, PloS one.

[20]  Mamoru Ito,et al.  A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. , 2008, The Journal of infectious diseases.

[21]  S. Devi,et al.  Dengue virus infection and immune response in humanized RAG2−/−γc−/− (RAG-hu) mice , 2007 .

[22]  Alan L Rothman,et al.  Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. , 2007, The Journal of infectious diseases.

[23]  Dale L. Greiner,et al.  Humanized mice in translational biomedical research , 2007, Nature Reviews Immunology.

[24]  A. Haase,et al.  Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1 , 2006, Nature Medicine.

[25]  Markus G. Manz,et al.  Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/−γc−/− mice , 2006, Proceedings of the National Academy of Sciences.

[26]  S. Green,et al.  Dengue Virus-Reactive CD8+ T Cells Display Quantitative and Qualitative Differences in Their Response to Variant Epitopes of Heterologous Viral Serotypes1 , 2006, The Journal of Immunology.

[27]  R. Rico-Hesse,et al.  Dengue Fever in Humanized NOD/SCID Mice , 2005, Journal of Virology.

[28]  K. Akashi,et al.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice , 2005 .

[29]  B. Murphy,et al.  An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus , 2004, Nature Medicine.

[30]  Markus G. Manz,et al.  Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.

[31]  Alan L Rothman,et al.  Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. , 2004, The Journal of infectious diseases.

[32]  A. Nisalak,et al.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.

[33]  D. Vaughn,et al.  Predominance of HLA-Restricted Cytotoxic T-Lymphocyte Responses to Serotype-Cross-Reactive Epitopes on Nonstructural Proteins following Natural Secondary Dengue Virus Infection , 1998, Journal of Virology.

[34]  A. Rothman,et al.  Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. , 1996, The Journal of clinical investigation.

[35]  D. Gubler,et al.  Dengue/dengue hemorrhagic fever: the emergence of a global health problem. , 1995, Emerging infectious diseases.

[36]  D. Gubler,et al.  Dengue and dengue hemorrhagic fever. , 2014 .

[37]  R. Lanciotti,et al.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction , 1992, Journal of clinical microbiology.